Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia.
Kaplan
Steven A
SA
D000368:Aged; D001378:Azasteroids / Q000009:adverse effects / Q000627:therapeutic use*; D001707:Biopsy, Needle; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D000068538:Dutasteride; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000032:analysis*; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000473:pathology*; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control*; D012016:Reference Values; D018570:Risk Assessment; D012720:Severity of Illness Index
D001378:Azasteroids; D017430:Prostate-Specific Antigen; D000068538:Dutasteride